Klaus Wagner
Direttore Tecnico/Scientifico/R&S presso BOUNDLESS BIO, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Klaus Wagner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BOUNDLESS BIO, INC. | Direttore Tecnico/Scientifico/R&S | 20/02/2022 | - |
Storia della carriera di Klaus Wagner
Precedenti posizioni note di Klaus Wagner
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INHIBRX, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2015 | 01/02/2022 |
Formazione di Klaus Wagner
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Germania | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Klaus Wagner
- Esperienza
